Assessing the safety of del Nido cardioplegia solution in adult congenital cases

G. Smigla, R. Jaquiss, R. Walczak, D. Bonadonna, D. Kaemmer, C. Schwimer, A. Lodge

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Results: The average duration of the longest ischemic time was 52.5 minutes ± 15.57 minutes. In patients receiving a single dose (40%, n=19) of CPS, the average ischemic time was 49.8 minutes ± 18.8 minutes. No patients demonstrated any ventricular electrical activity while the aorta was cross-clamped. Post-operative ECHO showed that 94% (n=44) had no change in ejection fraction from the pre-operative ECHO. Patients requiring inotropic support at the time of leaving the operating room (OR) was 43% (n=20). The percentage of patients requiring inotropic support twenty-four hours post-operatively was 17% (n=8). Spontaneous restoration of cardiac rhythm (without the need for defibrillation) after cross-clamp removal occurred in 91% (n=43) of patients. The average troponin T level post-op was 1.86 ± 2.9 μg/L.

Purpose: del Nido cardioplegia solution (CPS) has been successfully used for myocardial protection in the pediatric population. We propose this solution can be used safely in adult congenital patients. The proposed benefit of this solution is the avoidance of the need for repetitive interruption of the operation to administer multiple doses of standard cardioplegia.

Conclusions: del Nido CPS can be used for myocardial protection during adult congenital cardiac surgery without any apparent adverse effects. In addition, we were able to change our re-dosing protocol to 45 minutes with del Nido CPS compared to 20 minutes with our adult 4:1 blood CPS.

Original languageEnglish (US)
Pages (from-to)554-558
Number of pages5
JournalPerfusion (United Kingdom)
Volume29
Issue number6
DOIs
StatePublished - Jan 1 2014

Fingerprint

Induced Heart Arrest
Safety
restoration
surgery
Operating rooms
Troponin T
Pediatrics
Clamping devices
Operating Rooms
time
Surgery
Thoracic Surgery
Restoration
Aorta
Blood
Population

Keywords

  • adult congenital
  • cardioplegia
  • del Nido
  • ischemic time
  • myocardial protection

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging
  • Advanced and Specialized Nursing
  • Safety Research
  • Medicine(all)

Cite this

Smigla, G., Jaquiss, R., Walczak, R., Bonadonna, D., Kaemmer, D., Schwimer, C., & Lodge, A. (2014). Assessing the safety of del Nido cardioplegia solution in adult congenital cases. Perfusion (United Kingdom), 29(6), 554-558. https://doi.org/10.1177/0267659114543346

Assessing the safety of del Nido cardioplegia solution in adult congenital cases. / Smigla, G.; Jaquiss, R.; Walczak, R.; Bonadonna, D.; Kaemmer, D.; Schwimer, C.; Lodge, A.

In: Perfusion (United Kingdom), Vol. 29, No. 6, 01.01.2014, p. 554-558.

Research output: Contribution to journalArticle

Smigla, G, Jaquiss, R, Walczak, R, Bonadonna, D, Kaemmer, D, Schwimer, C & Lodge, A 2014, 'Assessing the safety of del Nido cardioplegia solution in adult congenital cases', Perfusion (United Kingdom), vol. 29, no. 6, pp. 554-558. https://doi.org/10.1177/0267659114543346
Smigla, G. ; Jaquiss, R. ; Walczak, R. ; Bonadonna, D. ; Kaemmer, D. ; Schwimer, C. ; Lodge, A. / Assessing the safety of del Nido cardioplegia solution in adult congenital cases. In: Perfusion (United Kingdom). 2014 ; Vol. 29, No. 6. pp. 554-558.
@article{e14f98a0d8ee473f9efe5422e60c18eb,
title = "Assessing the safety of del Nido cardioplegia solution in adult congenital cases",
abstract = "Results: The average duration of the longest ischemic time was 52.5 minutes ± 15.57 minutes. In patients receiving a single dose (40{\%}, n=19) of CPS, the average ischemic time was 49.8 minutes ± 18.8 minutes. No patients demonstrated any ventricular electrical activity while the aorta was cross-clamped. Post-operative ECHO showed that 94{\%} (n=44) had no change in ejection fraction from the pre-operative ECHO. Patients requiring inotropic support at the time of leaving the operating room (OR) was 43{\%} (n=20). The percentage of patients requiring inotropic support twenty-four hours post-operatively was 17{\%} (n=8). Spontaneous restoration of cardiac rhythm (without the need for defibrillation) after cross-clamp removal occurred in 91{\%} (n=43) of patients. The average troponin T level post-op was 1.86 ± 2.9 μg/L.Purpose: del Nido cardioplegia solution (CPS) has been successfully used for myocardial protection in the pediatric population. We propose this solution can be used safely in adult congenital patients. The proposed benefit of this solution is the avoidance of the need for repetitive interruption of the operation to administer multiple doses of standard cardioplegia.Conclusions: del Nido CPS can be used for myocardial protection during adult congenital cardiac surgery without any apparent adverse effects. In addition, we were able to change our re-dosing protocol to 45 minutes with del Nido CPS compared to 20 minutes with our adult 4:1 blood CPS.",
keywords = "adult congenital, cardioplegia, del Nido, ischemic time, myocardial protection",
author = "G. Smigla and R. Jaquiss and R. Walczak and D. Bonadonna and D. Kaemmer and C. Schwimer and A. Lodge",
year = "2014",
month = "1",
day = "1",
doi = "10.1177/0267659114543346",
language = "English (US)",
volume = "29",
pages = "554--558",
journal = "Perfusion (United Kingdom)",
issn = "0267-6591",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - Assessing the safety of del Nido cardioplegia solution in adult congenital cases

AU - Smigla, G.

AU - Jaquiss, R.

AU - Walczak, R.

AU - Bonadonna, D.

AU - Kaemmer, D.

AU - Schwimer, C.

AU - Lodge, A.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Results: The average duration of the longest ischemic time was 52.5 minutes ± 15.57 minutes. In patients receiving a single dose (40%, n=19) of CPS, the average ischemic time was 49.8 minutes ± 18.8 minutes. No patients demonstrated any ventricular electrical activity while the aorta was cross-clamped. Post-operative ECHO showed that 94% (n=44) had no change in ejection fraction from the pre-operative ECHO. Patients requiring inotropic support at the time of leaving the operating room (OR) was 43% (n=20). The percentage of patients requiring inotropic support twenty-four hours post-operatively was 17% (n=8). Spontaneous restoration of cardiac rhythm (without the need for defibrillation) after cross-clamp removal occurred in 91% (n=43) of patients. The average troponin T level post-op was 1.86 ± 2.9 μg/L.Purpose: del Nido cardioplegia solution (CPS) has been successfully used for myocardial protection in the pediatric population. We propose this solution can be used safely in adult congenital patients. The proposed benefit of this solution is the avoidance of the need for repetitive interruption of the operation to administer multiple doses of standard cardioplegia.Conclusions: del Nido CPS can be used for myocardial protection during adult congenital cardiac surgery without any apparent adverse effects. In addition, we were able to change our re-dosing protocol to 45 minutes with del Nido CPS compared to 20 minutes with our adult 4:1 blood CPS.

AB - Results: The average duration of the longest ischemic time was 52.5 minutes ± 15.57 minutes. In patients receiving a single dose (40%, n=19) of CPS, the average ischemic time was 49.8 minutes ± 18.8 minutes. No patients demonstrated any ventricular electrical activity while the aorta was cross-clamped. Post-operative ECHO showed that 94% (n=44) had no change in ejection fraction from the pre-operative ECHO. Patients requiring inotropic support at the time of leaving the operating room (OR) was 43% (n=20). The percentage of patients requiring inotropic support twenty-four hours post-operatively was 17% (n=8). Spontaneous restoration of cardiac rhythm (without the need for defibrillation) after cross-clamp removal occurred in 91% (n=43) of patients. The average troponin T level post-op was 1.86 ± 2.9 μg/L.Purpose: del Nido cardioplegia solution (CPS) has been successfully used for myocardial protection in the pediatric population. We propose this solution can be used safely in adult congenital patients. The proposed benefit of this solution is the avoidance of the need for repetitive interruption of the operation to administer multiple doses of standard cardioplegia.Conclusions: del Nido CPS can be used for myocardial protection during adult congenital cardiac surgery without any apparent adverse effects. In addition, we were able to change our re-dosing protocol to 45 minutes with del Nido CPS compared to 20 minutes with our adult 4:1 blood CPS.

KW - adult congenital

KW - cardioplegia

KW - del Nido

KW - ischemic time

KW - myocardial protection

UR - http://www.scopus.com/inward/record.url?scp=84912000862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912000862&partnerID=8YFLogxK

U2 - 10.1177/0267659114543346

DO - 10.1177/0267659114543346

M3 - Article

C2 - 25009226

AN - SCOPUS:84912000862

VL - 29

SP - 554

EP - 558

JO - Perfusion (United Kingdom)

JF - Perfusion (United Kingdom)

SN - 0267-6591

IS - 6

ER -